|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.56 USD | +0.92% |
|
+5.21% | -35.61% |
| 06-02 | Forte Biosciences Files $500 Million Mixed Shelf | MT |
| 05-11 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 20.07 | 22 | 35.09 |
| Spread/Res. | -12.51% | -20.18% | -49.96% |
| Spread/Supp. | +12.06% | +12.06% | +82.73% |
| Support | 15.67 | 15.67 | 9.61 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FBRX Stock
- Charts Forte Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
